Skip to main content
Top
Published in: Journal of General Internal Medicine 9/2007

Open Access 01-09-2007 | Original Article

Reliability, Validity and Responsiveness of the Syncope Functional Status Questionnaire

Authors: Nynke van Dijk, MD, PhD, Kimberly R. Boer, MSc., Wouter Wieling, MD, PhD, Mark Linzer, MD, Mirjam A. Sprangers, PhD

Published in: Journal of General Internal Medicine | Issue 9/2007

Login to get access

Abstract

BACKGROUND

Patients with transient loss of consciousness (TLOC) have poor health-related quality of life (HR-QoL).

OBJECTIVE

To test the reliability, validity, and responsiveness of the disease-specific Syncope Functional Status HR-QoL Questionnaire (SFSQ), which yields two summary scales—impairment score (IS) and fear–worry score (FWS).

DESIGN

Cohort-study.

PARTICIPANTS

503 adult patients presenting with TLOC.

MEASUREMENTS

HR-QoL was assessed using the SFSQ and the Short Form-36 (SF-36) after presentation and 1 year later. To test reliability, score distributions, internal consistency, and test–retest reliability were assessed. To assess validity, scores on the SFSQ and the SF-36 were compared. Clinical validity was tested using known-group comparison. Responsiveness was assessed by comparing changes in SFSQ scores with changes in health status and clinical condition.

RESULTS

Response rate was 82% at baseline and 72% at 1-year follow-up. For all scales the full range of scores was seen. Score distributions were asymmetrical. Internal consistency was high (alpha = 0.88 for IS, 0.92 for FWS). Test–retest reliability was moderate to good for individual items and high for summary scales (inter-class correlation = 0.78 for both IS and FWS). Correlations between SFSQ scores and the SF-36 were modest. The SFSQ did not discriminate between patients differing in age and gender but did discriminate between patients differing in number of episodes and comorbid conditions. Changes in SFSQ scores were related to changes in health status and the presence of recurrences but did not vary by TLOC diagnosis.

CONCLUSION

The SFSQ is an adequately reliable, valid, and responsive measure to assess HR-QoL in patients with TLOC.
Literature
1.
go back to reference Ganzeboom KS, Colman N, Reitsma JB, Shen WK, Wieling W. Prevalence and triggers of syncope in medical students. Am J Cardiol. 2003;91(8):1006–8.PubMedCrossRef Ganzeboom KS, Colman N, Reitsma JB, Shen WK, Wieling W. Prevalence and triggers of syncope in medical students. Am J Cardiol. 2003;91(8):1006–8.PubMedCrossRef
2.
go back to reference Ganzeboom KS, Mairuhu G, Reitsma J, Linzer M, Wieling W, van Dijk N. Lifetime cumulative incidence of syncope in the general population: a study of 549 Dutch subjects aged 35–60 years. J Cardiovasc Electrophysiol. 2006;17:1172–6.PubMedCrossRef Ganzeboom KS, Mairuhu G, Reitsma J, Linzer M, Wieling W, van Dijk N. Lifetime cumulative incidence of syncope in the general population: a study of 549 Dutch subjects aged 35–60 years. J Cardiovasc Electrophysiol. 2006;17:1172–6.PubMedCrossRef
3.
go back to reference Brignole M, Alboni P, Benditt DG, et al. Guidelines on management (diagnosis and treatment) of syncope—update 2004. Europace. 2004;6(6):467–537.PubMedCrossRef Brignole M, Alboni P, Benditt DG, et al. Guidelines on management (diagnosis and treatment) of syncope—update 2004. Europace. 2004;6(6):467–537.PubMedCrossRef
4.
go back to reference Kapoor WN. Evaluation and outcome of patients with syncope. Medicine (Baltimore). 1990;69(3):160–75. Kapoor WN. Evaluation and outcome of patients with syncope. Medicine (Baltimore). 1990;69(3):160–75.
5.
go back to reference Linzer M, Pontinen M, Gold DT, Divine GW, Felder A, Brooks WB. Impairment of physical and psychosocial function in recurrent syncope. J Clin Epidemiol. 1991;44(10):1037–43.PubMedCrossRef Linzer M, Pontinen M, Gold DT, Divine GW, Felder A, Brooks WB. Impairment of physical and psychosocial function in recurrent syncope. J Clin Epidemiol. 1991;44(10):1037–43.PubMedCrossRef
6.
go back to reference van Dijk N, Sprangers MA, Colman N, Boer KR, Wieling W, Linzer M. Clinical factors associated with quality of life in patients with transient loss of consciousness. J Cardiovasc Electrophysiol. 2006;17:998–1003.PubMedCrossRef van Dijk N, Sprangers MA, Colman N, Boer KR, Wieling W, Linzer M. Clinical factors associated with quality of life in patients with transient loss of consciousness. J Cardiovasc Electrophysiol. 2006;17:998–1003.PubMedCrossRef
7.
go back to reference van Dijk N, Sprangers MA, Boer KR, Colman N, Wieling W, Linzer M. Quality of life within one year following presentation after transient loss of consciousness. Am J Cardiol. 2007; in press. van Dijk N, Sprangers MA, Boer KR, Colman N, Wieling W, Linzer M. Quality of life within one year following presentation after transient loss of consciousness. Am J Cardiol. 2007; in press.
8.
go back to reference Sheldon R, Rose S, Flanagan P, Koshman ML, Killam S. Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope. Circulation. 1996;93(5):973–81.PubMed Sheldon R, Rose S, Flanagan P, Koshman ML, Killam S. Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope. Circulation. 1996;93(5):973–81.PubMed
9.
go back to reference Linzer M, Gold DT, Pontinen M, Divine GW, Felder A, Brooks WB. Recurrent syncope as a chronic disease: preliminary validation of a disease-specific measure of functional impairment. J Gen Intern Med. 1994;9(4):181–6.PubMedCrossRef Linzer M, Gold DT, Pontinen M, Divine GW, Felder A, Brooks WB. Recurrent syncope as a chronic disease: preliminary validation of a disease-specific measure of functional impairment. J Gen Intern Med. 1994;9(4):181–6.PubMedCrossRef
10.
go back to reference Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care. 1981;19(8):787–805.PubMedCrossRef Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care. 1981;19(8):787–805.PubMedCrossRef
11.
go back to reference Derogatis LR. SCL-90-R. Administration scoring and procedures manual. Baltimore, MD: Clinical Psychometric Research; 1977. Derogatis LR. SCL-90-R. Administration scoring and procedures manual. Baltimore, MD: Clinical Psychometric Research; 1977.
12.
go back to reference Terwee CB, Bot SD, De Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60:34–42.PubMedCrossRef Terwee CB, Bot SD, De Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60:34–42.PubMedCrossRef
13.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.PubMedCrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.PubMedCrossRef
14.
go back to reference Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health survey manual and interpretation guide. Boston, MA: The Health Institute, New England Medical Center; 1993. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health survey manual and interpretation guide. Boston, MA: The Health Institute, New England Medical Center; 1993.
15.
go back to reference Aaronson NK, Muller M, Cohen PD, et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol. 1998;51(11):1055–68.PubMedCrossRef Aaronson NK, Muller M, Cohen PD, et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol. 1998;51(11):1055–68.PubMedCrossRef
16.
go back to reference Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. Control Clin Trials. 1991;12(4 Suppl):142S–58S.PubMedCrossRef Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. Control Clin Trials. 1991;12(4 Suppl):142S–58S.PubMedCrossRef
17.
go back to reference Kuder GF, Richardson MW. The theory of the estimation of test reliability. Psychometrika. 1937;2:151–60.CrossRef Kuder GF, Richardson MW. The theory of the estimation of test reliability. Psychometrika. 1937;2:151–60.CrossRef
18.
go back to reference Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297.CrossRef Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297.CrossRef
19.
go back to reference Kerlinger FN. Foundations of Behavioral Research. New York, NY: Holt, Rinehart and Winston; 1973. Kerlinger FN. Foundations of Behavioral Research. New York, NY: Holt, Rinehart and Winston; 1973.
20.
go back to reference Rose MS, Koshman ML, Spreng S, Sheldon R. The relationship between health-related quality of life and frequency of spells in patients with syncope. J Clin Epidemiol. 2000;53(12):1209–16.PubMedCrossRef Rose MS, Koshman ML, Spreng S, Sheldon R. The relationship between health-related quality of life and frequency of spells in patients with syncope. J Clin Epidemiol. 2000;53(12):1209–16.PubMedCrossRef
21.
go back to reference Baron-Esquivias G, Cayuela A, Gomez S, et al. Quality of life in patients with vasovagal syncope. Clinical parameters influence. Med Clin (Barc). 2003;121(7):245–9.CrossRef Baron-Esquivias G, Cayuela A, Gomez S, et al. Quality of life in patients with vasovagal syncope. Clinical parameters influence. Med Clin (Barc). 2003;121(7):245–9.CrossRef
22.
go back to reference Guyatt G, Walter S, Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis. 1987;40(2):171–8.PubMedCrossRef Guyatt G, Walter S, Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis. 1987;40(2):171–8.PubMedCrossRef
23.
go back to reference Muller R, Buttner P. A critical discussion of intraclass correlation coefficients. Stat Med. 1994;13(23–24):2465–76.PubMedCrossRef Muller R, Buttner P. A critical discussion of intraclass correlation coefficients. Stat Med. 1994;13(23–24):2465–76.PubMedCrossRef
24.
go back to reference Baron-Esquivias G, Gomez S, Aguilera A, et al. Short-term evolution of vasovagal syncope: Influence on the quality of life. Int J Cardiol. 2005;102(2):315–9.PubMedCrossRef Baron-Esquivias G, Gomez S, Aguilera A, et al. Short-term evolution of vasovagal syncope: Influence on the quality of life. Int J Cardiol. 2005;102(2):315–9.PubMedCrossRef
Metadata
Title
Reliability, Validity and Responsiveness of the Syncope Functional Status Questionnaire
Authors
Nynke van Dijk, MD, PhD
Kimberly R. Boer, MSc.
Wouter Wieling, MD, PhD
Mark Linzer, MD
Mirjam A. Sprangers, PhD
Publication date
01-09-2007
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 9/2007
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-007-0266-5

Other articles of this Issue 9/2007

Journal of General Internal Medicine 9/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.